Showing results (171-180 of 291) with videos related to

Sort By:
Pageof 30
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2017
Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in RemissionKristin M Page, Myriam Labopin, Annalisa Ruggeri, et al.
Blood|November 15, 2007
Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemiaSophie Archambeault, Nikki J Flores, Ayami Yoshimi, et al.
British Journal of Haematology|May 10, 2005
Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemiaAyami Yoshimi, Charlotte M Niemeyer, Viktoria Bohmer, et al.
Children (Basel, Switzerland)|August 27, 2021
Specialized Pediatric Palliative Care Services in Pediatric Hematopoietic Stem Cell Transplant CentersHilda Mekelenkamp, Teija Schröder, Eugenia Trigoso, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 2016
Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor AnalysisAnnalisa Ruggeri, Fernanda Volt, Franco Locatelli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Myeloablative Unrelated Cord Blood Transplantation in Adolescents and Young Adults with Acute LeukemiaHiromi Hayashi, Fernanda Volt, Jaime Sanz, et al.
Frontiers in Immunology|February 18, 2025
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcomaLaura M Moser, Catrin Heim, Sebastian E Koschade, et al.
The Lancet. Haematology|September 9, 2022
Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort studySara Ghorashian, Elad Jacoby, Barbara De Moerloose, et al.
Transplantation and Cellular Therapy|January 12, 2022
Mother Donors Improve Outcomes after HLA Haploidentical Transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow TransplantationLoredana Ruggeri, Dirk-Jan Eikema, Attilio Bondanza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trialPeter Bader, Hermann Kreyenberg, Arend von Stackelberg, et al.
Pageof 30